email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
421 - 435
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Zai Lab Acquires Global Rights to ADC for Small Cell Lung Cancer from MediLink
$5.00
Available
Adcentrx, a San Diego-Shanghai Company, Raises $38 Million for ADC Portfolio
$5.00
Available
Hasten Bio of Hefei Raises $315 Million for Product Acquisitions
$5.00
Available
CARsgen CAR-T Approved to Start China Trials for Pancreatic Cancer
$5.00
Available
Pfizer Partners with Sinopharm to Bring 12 Innovative Drugs to China
$5.00
Available
XtalPi/Merck Collaboration Uses AI + Wet Lab to Improve Crystal Morphology
$5.00
Available
Junshi Bio’s PARP Inhibitor Effective as Maintenance Therapy for Ovarian Cancer
$5.00
Available
Bridge Bio Doses First Patient in Phase II Trial of ATX Inhibitor for Fibrosis
$5.00
Available
VintaBio Opens Cell and Gene Therapy CDMO after $64 Million Round led by Decheng
$5.00
Available
Sirnaomics Starts US Phase I Trial of RNAi Anticoagulant
$5.00
Available
OnCusp to Post Data on Lead Candidate, an Anti-CDH6 ADC
$5.00
Available
Genor Reports CDK4/6 Inhibitor NDA Under Review in China for Breast Cancer
$5.00
Available
JW Therapeutics Starts China Trial of CAR-T for Systemic Lupus Erythematosus
$5.00
Available
Mabwell Says Nectin-4 ADC Posts Positive Results in Solid Tumor Cancers
$5.00
Available
Evopoint to Start China Trial of EZH2 Inhibitor Combined with Merck/MSD’s Keytruda
$5.00
Available